MIC Capital Management UK LLP
Follow13F filer, CIK 1889830, LONDON, United Kingdom
MIC Capital Management UK LLP reported $394,346,426 across 16 holdings for the quarter ended 2026-06-30, in a 13F-HR filed 2026-08-10. Its ten largest share positions make up 94.65% of the portfolio.
Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001889830-26-000003
- Period
- 2026-06-30
- Reported value
- $394M
- Holdings
- 16
- Top 10 weight
- 94.65%
- New
- 3
- Sold out
- 1
Largest buys vs the previous quarter
| Security | Shares change | Approx. value |
|---|---|---|
| BABAnew | +150,000 | $14.4M |
| COFnew | +48,011 | $9.63M |
| BLLNnew | +4,892 | $587K |
| RXRXadded | +1 | $3 |
Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.
Largest sells vs the previous quarter
| Security | Shares change | Approx. value |
|---|---|---|
| RVMDreduced | -264,000 | -$49.4M |
| KLARreduced | -1,862,430 | -$37.7M |
| INSGexited | -767,165 | -$8.53M |
| HAYWreduced | -401,149 | -$6.94M |
Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.
Holdings, Q2 2026
Share positions as resolved from 13F-HR 0001889830-26-000003, largest first. % of portfolio is the value over $394,346,426, the sum of the share positions whose value is usable for ratios (method).
| Security | History | Shares | Value | % of portfolio | Change | Latest event | Timeline |
|---|---|---|---|---|---|---|---|
| HAYWHAYWARD HLDGS INC | 6,171,527 | $107M | 27.09% | -401,149 | Timeline | ||
| RVMDREVOLUTION MEDICINES INC | 531,733 | $99.6M | 25.25% | -264,000 | Timeline | ||
| RXRXRECURSION PHARMACEUTICALS IN | 9,644,033 | $35.4M | 8.98% | +1 | Timeline | ||
| QSRRESTAURANT BRANDS INTL INC | 386,203 | $28M | 7.1% | 0 | Timeline | ||
| CPNGCOUPANG INC | 1,412,946 | $24.5M | 6.22% | 0 | Timeline | ||
| GRABGRAB HOLDINGS LIMITED | 5,000,000 | $18.9M | 4.78% | 0 | Timeline | ||
| METAMETA PLATFORMS INC | 33,300 | $18.8M | 4.76% | 0 | Timeline | ||
| KLARKLARNA GROUP PLC | 852,498 | $17.3M | 4.38% | -1,862,430 | Timeline | ||
| BABAALIBABA GROUP HLDG LTD | 150,000 | $14.4M | 3.65% | new | Timeline | ||
| COFCAPITAL ONE FINL CORP | 48,011 | $9.63M | 2.44% | new | Timeline | ||
| NMRANEUMORA THERAPEUTICS INC. | 4,460,700 | $7.58M | 1.92% | 0 | Timeline | ||
| MNDYMONDAY COM LTD | 66,000 | $4.78M | 1.21% | 0 | Timeline | ||
| RKLBROCKET LAB CORP | 35,628 | $3.62M | 0.92% | 0 | Timeline | ||
| ACHRARCHER AVIATION INC | 700,000 | $3.31M | 0.84% | 0 | Timeline | ||
| LYELLYELL IMMUNOPHARMA INC | 87,028 | $1.22M | 0.31% | 0 | Timeline | ||
| BLLNBILLIONTOONE INC | 4,892 | $587K | 0.15% | new | Timeline |
Sold out in Q2 2026
Positions in the previous quarter's report that this quarter's report no longer lists.
| Security | Shares before | Value before | Type |
|---|---|---|---|
| INSGINSEEGO CORP | 767,165 | $8.53M | shares |
How Q2 2026 was built
Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).
| Filing | Role | Amendment | Filed | Accepted | Ingested |
|---|---|---|---|---|---|
| 13F-HR 0001889830-26-000003 | base | 2026-08-10 | acceptance time not in the bulk data set |
Filings
Every filing of this filer: 13F reports and notices, the 13D and 13G it filed or is a reporting person of, and Forms 3, 4 and 5 it reported as an owner.
| Filing | Subject | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001889830-26-000003 | Quarter ended 2026-06-30 | 2026-08-10 | acceptance time not in the bulk data set | |
| 13F-HR 0001889830-26-000002 | Quarter ended 2026-03-31 | 2026-05-13 | acceptance time not in the bulk data set | |
| 13F-HR 0001889830-26-000001 | Quarter ended 2025-12-31 | 2026-02-17 | acceptance time not in the bulk data set | |
| 13F-HR 0001889830-25-000003 | Quarter ended 2025-09-30 | 2025-11-14 | acceptance time not in the bulk data set | |
| 13F-HR 0001085146-25-005259 | Quarter ended 2025-06-30 | 2025-08-14 | acceptance time not in the bulk data set | |
| 13F-HR 0001085146-25-003296 | Quarter ended 2025-03-31 | 2025-05-15 | acceptance time not in the bulk data set | |
| 13F-HR 0001085146-25-001664 | Quarter ended 2024-12-31 | 2025-02-14 | acceptance time not in the bulk data set | |
| 13F-HR 0001085146-24-005936 | Quarter ended 2024-09-30 | 2024-11-14 | acceptance time not in the bulk data set | |
| 13F-HR 0001085146-24-003969 | Quarter ended 2024-06-30 | 2024-08-14 | acceptance time not in the bulk data set | |
| 13F-HR 0001085146-24-002607 | Quarter ended 2024-03-31 | 2024-05-15 | acceptance time not in the bulk data set | |
| 13F-HR 0001085146-24-001476 | Quarter ended 2023-12-31 | 2024-02-14 | acceptance time not in the bulk data set | |
| 13F-HR 0001085146-23-004467 | Quarter ended 2023-09-30 | 2023-11-14 | acceptance time not in the bulk data set | |
| 13F-HR 0001315863-23-000718 | Quarter ended 2023-06-30 | 2023-08-14 | acceptance time not in the bulk data set | |
| 13F-HR 0001315863-23-000544 | Quarter ended 2023-03-31 | 2023-05-15 | acceptance time not in the bulk data set | |
| 13F-HR 0001315863-23-000322 | Quarter ended 2022-12-31 | 2023-02-14 | acceptance time not in the bulk data set | |
| 13F-HR/A 0001315863-22-000791 | Quarter ended 2022-09-30 | 2022-11-15 | acceptance time not in the bulk data set | |
| 13F-HR 0001315863-22-000783 | Quarter ended 2022-09-30 | 2022-11-14 | acceptance time not in the bulk data set | |
| 13F-HR 0001315863-22-000574 | Quarter ended 2022-06-30 | 2022-08-15 | acceptance time not in the bulk data set | |
| 13F-HR 0001315863-22-000398 | Quarter ended 2022-03-31 | 2022-05-16 | acceptance time not in the bulk data set | |
| 13F-HR 0001315863-22-000143 | Quarter ended 2021-12-31 | 2022-02-14 | acceptance time not in the bulk data set |